Because the activation of the ATM-regulated DNA-damage response (DDR) network machinery is one of the earliest molecular events in the multistep progression of human epithelial carcinomas that impedes their evolution toward invasive malignancy, the selective activation of ATM with respect to DNA damage repair surveillance may directly contribute to metformin's cancer-preventive properties. The gene discussed is ATM; the disease is cancer.